These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2161534)

  • 1. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism.
    Yoshimura A; D'Andrea AD; Lodish HF
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4139-43. PubMed ID: 2161534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.
    Li JP; D'Andrea AD; Lodish HF; Baltimore D
    Nature; 1990 Feb; 343(6260):762-4. PubMed ID: 2154701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the erythropoietin receptor by the Friend spleen focus-forming virus gp55 glycoprotein induces constitutive protein tyrosine phosphorylation.
    Showers MO; Moreau JF; Linnekin D; Druker B; D'Andrea AD
    Blood; 1992 Dec; 80(12):3070-8. PubMed ID: 1467516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55.
    Li JP; Hu HO; Niu QT; Fang C
    J Virol; 1995 Mar; 69(3):1714-19. PubMed ID: 7853508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface organization of the erythropoietin receptor complex differs depending on its mode of activation.
    Tarr K; Watowich SS; Longmore GD
    J Biol Chem; 1997 Apr; 272(14):9099-107. PubMed ID: 9083037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein.
    Zon LI; Moreau JF; Koo JW; Mathey-Prevot B; D'Andrea AD
    Mol Cell Biol; 1992 Jul; 12(7):2949-57. PubMed ID: 1320192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene.
    Hoatlin ME; Kozak SL; Lilly F; Chakraborti A; Kozak CA; Kabat D
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9985-9. PubMed ID: 2175917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line.
    Showers MO; DeMartino JC; Saito Y; D'Andrea AD
    Mol Cell Biol; 1993 Feb; 13(2):739-48. PubMed ID: 8423798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains.
    D'Andrea AD; Yoshimura A; Youssoufian H; Zon LI; Koo JW; Lodish HF
    Mol Cell Biol; 1991 Apr; 11(4):1980-7. PubMed ID: 1848667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Friend virus mutant that overcomes Fv-2rr host resistance encodes a small glycoprotein that dimerizes, is processed to cell surfaces, and specifically activates erythropoietin receptors.
    Kozak SL; Hoatlin ME; Ferro FE; Majumdar MK; Geib RW; Fox MT; Kabat D
    J Virol; 1993 May; 67(5):2611-20. PubMed ID: 8474164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation.
    Barber DL; DeMartino JC; Showers MO; D'Andrea AD
    Mol Cell Biol; 1994 Apr; 14(4):2257-65. PubMed ID: 8139531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk.
    Nishigaki K; Thompson D; Hanson C; Yugawa T; Ruscetti S
    J Virol; 2001 Sep; 75(17):7893-903. PubMed ID: 11483734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin receptor binds to Friend virus gp55 through other membrane components.
    Kishi A; Chiba T; Sugiyama M; Machide M; Nagata Y; Amanuma H; Taira H; Katsumata T; Todokoro K
    Biochem Biophys Res Commun; 1993 May; 192(3):1131-8. PubMed ID: 8507186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of the erythropoietin receptor and gp55.
    D'Andrea AD
    Cancer Surv; 1992; 15():19-36. PubMed ID: 1451111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the structure-function relationship of the leukemogenic membrane glycoprotein (GP55) of Friend spleen focus-forming virus (F-SFFV).
    Amanuma H; Yugawa T; Watanabe N; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():160-1. PubMed ID: 9209329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes.
    Neumann D; Wikström L; Watowich SS; Lodish HF
    J Biol Chem; 1993 Jun; 268(18):13639-49. PubMed ID: 8514796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired activation and binding of the erythropoietin receptor by a mutant gp55 of Friend spleen focus-forming virus, which has a cytoplasmic domain.
    Yugawa T; Amanuma H
    Virology; 1998 Jul; 246(2):232-40. PubMed ID: 9657942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus.
    Ferro FE; Kozak SL; Hoatlin ME; Kabat D
    J Biol Chem; 1993 Mar; 268(8):5741-7. PubMed ID: 8449938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the erythropoietin receptor with protein tyrosine kinase activity.
    Linnekin D; Evans GA; D'Andrea A; Farrar WL
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6237-41. PubMed ID: 1378622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide.
    Lin TS; Ishiguro K; Sartorelli AC
    Oncol Res; 1998; 10(4):175-84. PubMed ID: 9778688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.